13G Filing: Balyasny Asset Management and Sunesis Pharmaceuticals Inc (SNSS)

Page 18 of 30

Page 18 of 30 – SEC Filing


Item 3	If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:

	Not Applicable

Item 4	Ownership:

	AMF

	(a)	Amount Beneficially Owned:

			224,506

	(b)	Percent of Class:

			1.05%

	(c)	Number of Shares as to which person has:

		(i)	Sole power to vote or to direct vote:

			224,506

		(ii)	Shared power to vote or to direct vote:

			None

		(iii)	Sole power to dispose or direct disposition of:

			224,506

		(iv)	Shared power to dispose or to direct disposition of:

			None

	AG

	(a)	Amount Beneficially Owned:

		By virtue of its ownership of 20.43% of the equity interest in AMF, AG may be deemed to beneficially own the 224,506 Shares of the Companys Common Stock beneficially owned by AMF.

Page 18 of 30 Pages

We may use your email to send marketing emails about our services. Click here to read our privacy policy.

Page 18 of 30